**Question:** Which of the following is the drug of choice to treat endometriosis:

A. Oral contraceptives
B. Gonadotropin-releasing hormone (GnRH) agonists
C. Anti-inflammatory drugs
D. Progestins

**Core Concept:** Endometriosis is a chronic, estrogen-dependent disease characterized by the presence of endometrial-like tissue outside the uterus, causing pain and infertility. Treatment options aim to reduce endometriosis-associated inflammation, pain, and hormonal imbalance.

**Why the Correct Answer is Right:** Gonadotropin-releasing hormone (GnRH) agonists, such as leuprolide and buserelin, are the drug of choice for treating endometriosis. They work by directly suppressing the pituitary gland, leading to a decrease in luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels, which in turn reduces the synthesis of estrogen in the ovaries. This results in a temporary state of ovarian hypoestrogenism, which leads to a decrease in endometriotic lesion growth, inflammation, and pain.

**Why Each Wrong Option is Incorrect:**

A. Oral contraceptives (OCs) are also used for endometriosis treatment but primarily work by suppressing the synthesis of both estrogen and progesterone in the ovaries. While they can reduce endometriotic lesion growth and pain, their use is limited due to potential side effects, such as venous thromboembolism, breast tenderness, and increased risk of stroke, myocardial infarction, and deep vein thrombosis.

B. Anti-inflammatory drugs, like nonsteroidal anti-inflammatory drugs (NSAIDs), are used for pain relief in endometriosis. However, their long-term use may lead to gastrointestinal complications like gastritis, ulcers, and bleeding, which can outweigh their benefits in severe cases.

C. Progestins, like medroxyprogesterone and norethisterone, are used to suppress endometrial growth and reduce pain. However, they do not address the underlying hormonal imbalance associated with endometriosis and rarely lead to a significant reduction in the size of endometriotic lesions.

**Clinical Pearls:**

1. When choosing a hormonal therapy for endometriosis, consider the potential side effects and complications associated with each drug class.
2. Given the unique hormonal imbalances in endometriosis, a combination therapy involving both anti-inflammatory and anti-estrogenic agents may be beneficial for optimal pain relief and lesion reduction.
3. Non-hormonal treatments, such as physical therapy, pelvic floor muscle rehabilitation, and acupuncture, should be considered in mild to moderate cases of endometriosis to avoid complications associated with hormonal therapy.